{"id":"https://openalex.org/W2603199396","doi":"https://doi.org/10.1002/clc.22687","title":"A phase 1 study to evaluate the safety and LDL cholesterol\u2013lowering effects of RG7652 , a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9","display_name":"A phase 1 study to evaluate the safety and LDL cholesterol\u2013lowering effects of RG7652 , a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9","publication_year":2017,"publication_date":"2017-03-22","ids":{"openalex":"https://openalex.org/W2603199396","doi":"https://doi.org/10.1002/clc.22687","mag":"2603199396","pmid":"https://pubmed.ncbi.nlm.nih.gov/28326559","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6490403"},"language":"en","primary_location":{"id":"doi:10.1002/clc.22687","doi":"https://doi.org/10.1002/clc.22687","is_oa":true,"landing_page_url":"https://doi.org/10.1002/clc.22687","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22687","source":{"id":"https://openalex.org/S82037729","display_name":"Clinical Cardiology","issn_l":"0160-9289","issn":["0160-9289","1932-8737"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cardiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22687","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Amos Baruch","orcid":"https://orcid.org/0000-0002-7940-8150","observed_orcids":["https://orcid.org/0000-0002-7940-8150"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amos Baruch","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0002-7940-8150","affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109944443","display_name":"Diana Luca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana Luca","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert S. Kahn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert S. Kahn","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082898036","display_name":"Kyra J. Cowan","orcid":"https://orcid.org/0000-0002-4811-7748","observed_orcids":["https://orcid.org/0000-0002-4811-7748"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyra J. Cowan","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046377363","display_name":"Maya K. Leabman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maya Leabman","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078590150","display_name":"Nageshwar R. Budha","orcid":"https://orcid.org/0009-0005-3373-657X","observed_orcids":["https://orcid.org/0009-0005-3373-657X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nageshwar R. Budha","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082749535","display_name":"Cecilia Chiu","orcid":"https://orcid.org/0000-0001-8797-9984","observed_orcids":["https://orcid.org/0000-0001-8797-9984"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cecilia P.C. Chiu","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028092177","display_name":"Yan Wu","orcid":"https://orcid.org/0000-0003-2734-0673","observed_orcids":["https://orcid.org/0000-0003-2734-0673"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Wu","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072975032","display_name":"Daniel Kirchhofer","orcid":"https://orcid.org/0000-0002-0975-4402","observed_orcids":["https://orcid.org/0000-0002-0975-4402"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Kirchhofer","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028349586","display_name":"Andrew S. Peterson","orcid":"https://orcid.org/0000-0002-7847-1940","observed_orcids":["https://orcid.org/0000-0002-7847-1940"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Peterson","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002503854","display_name":"John D. Davis","orcid":"https://orcid.org/0000-0001-6282-1670","observed_orcids":["https://orcid.org/0000-0001-6282-1670"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Davis Jr","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109355222","display_name":"Whittemore G. Tingley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Whittemore G. Tingley","raw_affiliation_strings":["Genentech Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109355222"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":3810,"currency":"USD","value_usd":3810},"apc_paid":null,"fwci":3.3601,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.92086229,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"40","issue":"7","first_page":"503","last_page":"511"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9-inhibition","display_name":"PCSK9 inhibition","score":0.8069999814033508},{"id":"https://openalex.org/keywords/pcsk9","display_name":"PCSK9","score":0.9300000071525574},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8579999804496765},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.9890000224113464},{"id":"https://openalex.org/keywords/ldl-receptor","display_name":"LDL receptor","score":0.6710000038146973},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6940000057220459},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7919999957084656},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.7689999938011169},{"id":"https://openalex.org/keywords/oxidized-ldl","display_name":"oxidized LDL","score":0.8230000138282776},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lipoprotein-associated-phospholipase-a2","display_name":"lipoprotein-associated phospholipase A2","score":0.996999979019165},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.9362072348594666},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8959167003631592},{"id":"https://openalex.org/C2778849439","wikidata":"https://www.wikidata.org/wiki/Q6397985","display_name":"Kexin","level":5,"score":0.7798025012016296},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.5927685499191284},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5838223695755005},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5778378248214722},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5659320950508118},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5094667077064514},{"id":"https://openalex.org/C2778824825","wikidata":"https://www.wikidata.org/wiki/Q7250439","display_name":"Proprotein convertase","level":5,"score":0.4978454113006592},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.4864751994609833},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4656798243522644},{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.44995102286338806},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4311727285385132},{"id":"https://openalex.org/C2780499067","wikidata":"https://www.wikidata.org/wiki/Q415159","display_name":"Rosuvastatin","level":2,"score":0.42289212346076965},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4156051278114319},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.3951018154621124},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.36988550424575806},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05970543622970581},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/clc.22687","doi":"https://doi.org/10.1002/clc.22687","is_oa":true,"landing_page_url":"https://doi.org/10.1002/clc.22687","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22687","source":{"id":"https://openalex.org/S82037729","display_name":"Clinical Cardiology","issn_l":"0160-9289","issn":["0160-9289","1932-8737"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cardiology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6490403","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6490403","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Cardiol","raw_type":"Text"},{"id":"pmid:28326559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28326559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cardiology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1002/clc.22687","doi":"https://doi.org/10.1002/clc.22687","is_oa":true,"landing_page_url":"https://doi.org/10.1002/clc.22687","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22687","source":{"id":"https://openalex.org/S82037729","display_name":"Clinical Cardiology","issn_l":"0160-9289","issn":["0160-9289","1932-8737"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cardiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2603199396.pdf","grobid_xml":"https://content.openalex.org/works/W2603199396.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W72392028","https://openalex.org/W162053157","https://openalex.org/W1989730880","https://openalex.org/W2001313012","https://openalex.org/W2001592913","https://openalex.org/W2040612932","https://openalex.org/W2053513183","https://openalex.org/W2067539811","https://openalex.org/W2080443045","https://openalex.org/W2086717183","https://openalex.org/W2093535758","https://openalex.org/W2103647780","https://openalex.org/W2104355263","https://openalex.org/W2108956796","https://openalex.org/W2114408062","https://openalex.org/W2117011155","https://openalex.org/W2143064104","https://openalex.org/W2172024977","https://openalex.org/W2569152759"],"related_works":["https://openalex.org/W2333935878","https://openalex.org/W1977443017","https://openalex.org/W2593472072","https://openalex.org/W2026465846","https://openalex.org/W1989730880","https://openalex.org/W2105872402","https://openalex.org/W2086942972","https://openalex.org/W2318171295","https://openalex.org/W2055814339","https://openalex.org/W2151731574"],"abstract_inverted_index":{"BACKGROUND:":[0],"Proprotein":[1],"convertase":[2],"subtilisin/kexin":[3],"type":[4],"9":[5],"(PCSK9)":[6],"downregulates":[7],"low-density":[8],"lipoprotein":[9],"(LDL)":[10],"receptors,":[11],"thereby":[12],"leading":[13,133],"to":[14,134,150,217],"a":[15,24,49,172],"rise":[16],"in":[17,37,197,204],"circulating":[18],"LDL":[19],"cholesterol":[20],"(LDL-C).":[21],"RG7652":[22,44,86,99,142,174,194,229],"is":[23],"fully":[25],"human":[26],"monoclonal":[27],"antibody":[28,55,192],"against":[29,193],"PCSK9.":[30],"This":[31],"placebo-controlled,":[32],"phase":[33],"1":[34],"ascending-dose":[35],"study":[36],"healthy":[38],"subjects":[39],"evaluated":[40],"the":[41,119,161,219],"safety":[42,240],"of":[43,85,98,199,206,225],"and":[45,58,152,164,185,203,232,242],"its":[46],"efficacy":[47],"as":[48,153,155],"potential":[50],"LDL-C-lowering":[51],"drug.":[52],"HYPOTHESIS:":[53],"Anti-PCSK9":[54],"therapy":[56,110],"safely":[57],"effectively":[59],"reduces":[60],"LDL-C.":[61],"METHODS:":[62],"Subjects":[63],"(N":[64],"=":[65],"80)":[66],"were":[67,116,123,140],"randomized":[68],"into":[69],"10":[70],"cohorts.":[71],"Six":[72],"sequential":[73],"single-dose":[74],"cohorts":[75,92],"received":[76,93],"10,":[77],"40,":[78],"150,":[79],"300,":[80],"600,":[81],"or":[82,95,107,137,222],"800":[83],"mg":[84,97],"via":[87],"subcutaneous":[88],"injection.":[89],"Four":[90],"multiple-dose":[91],"40":[94],"150":[96],"once":[100],"weekly":[101],"for":[102],"4":[103,205],"weeks,":[104],"either":[105],"with":[106,167,189,237],"without":[108],"statin":[109],"(atorvastatin).":[111],"RESULTS:":[112],"Adverse":[113],"events":[114],"(AEs)":[115],"generally":[117],"mild;":[118],"most":[120],"common":[121],"AEs":[122,132],"temporary":[124],"injection-site":[125],"reactions.":[126],"No":[127],"serious":[128],"AEs,":[129,131],"severe":[130],"study-drug":[135],"discontinuation,":[136],"dose-limiting":[138],"toxicities":[139],"reported.":[141],"monotherapy":[143],"reduced":[144,181],"mean":[145],"LDL-C":[146,235],"levels":[147],"by":[148],"up":[149],"64%":[151],"much":[154],"100":[156],"mg/dL":[157],"at":[158],"week":[159],"2;":[160],"effect":[162],"magnitude":[163],"duration":[165],"increased":[166],"dose":[168,175],"(\u226557":[169],"days":[170],"following":[171],"single":[173],"\u2265300":[176],"mg).":[177],"Exploratory":[178],"analyses":[179],"showed":[180],"oxidized":[182],"LDL,":[183],"lipoprotein(a),":[184],"lipoprotein-associated":[186],"phospholipase":[187],"A2":[188],"RG7652.":[190,226],"Antidrug":[191],"tested":[195],"positive":[196],"2":[198],"60":[200],"(3.3%)":[201],"RG7652-treated":[202],"20":[207],"(20.0%)":[208],"placebo-treated":[209],"subjects.":[210],"Simultaneous":[211],"atorvastatin":[212],"administration":[213],"did":[214],"not":[215],"appear":[216],"impact":[218],"pharmacokinetic":[220],"profile":[221,241],"lipid-lowering":[223],"effects":[224],"CONCLUSIONS:":[227],"Overall,":[228],"elicited":[230],"substantial":[231],"sustained":[233],"dose-related":[234],"reductions":[236],"an":[238],"acceptable":[239],"minimal":[243],"immunogenicity.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-04-07T00:00:00"}